Richard U. De Schutter Appointed to Varian, Inc. Board of Directors

27-Nov-2001

Varian, Inc. (Nasdaq:VARI) today announced that Richard U. De Schutter has been appointed to its board of directors. De Schutter, formerly the Executive Chairman, President and Chief Executive Officer of DuPont Pharmaceuticals Company, is the sixth member of Varian, Inc.'s board.

De Schutter has a distinguished background and reputation in the pharmaceutical industry and served as chief executive officer of G.D. Searle & Company prior to joining Dupont Pharmaceuticals in 2000.

"We are very pleased to have Richard De Schutter as a member of the Varian, Inc. board," said Allen J. Lauer, president and CEO, Varian, Inc. "The company's primary strategy continues to be expanding our drive into life science applications of our products, particularly into pharmaceutical labs. Richard's exceptional background in the pharmaceutical industry and his diverse experience in managing international companies are invaluable assets to Varian, Inc. as we continue to execute our business goals."

De Schutter's other current board memberships include ING Americas; General Binding Corporation; Smith & Nephew plc, and Medpointe. He also serves on the Advisory Board of University of Arizona.

De Schutter received his bachelor's of science and M.A. in chemical engineering from the University of Arizona.

Other news from the department people

Most read news

More news from our other portals

Discover the latest developments in battery technology!